116 related articles for article (PubMed ID: 33048448)
1. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
Chiem K; Ye C; Martinez-Sobrido L
Curr Protoc Microbiol; 2020 Dec; 59(1):e126. PubMed ID: 33048448
[TBL] [Abstract][Full Text] [Related]
2. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
3. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
[TBL] [Abstract][Full Text] [Related]
4. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
bioRxiv; 2020 Jul; ():. PubMed ID: 32743573
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2.
Chiem K; Nogales A; Almazán F; Ye C; Martínez-Sobrido L
Methods Mol Biol; 2024; 2733():133-153. PubMed ID: 38064031
[TBL] [Abstract][Full Text] [Related]
6. Growth, detection, quantification, and inactivation of SARS-CoV-2.
Case JB; Bailey AL; Kim AS; Chen RE; Diamond MS
Virology; 2020 Sep; 548():39-48. PubMed ID: 32838945
[TBL] [Abstract][Full Text] [Related]
7. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
8. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
[TBL] [Abstract][Full Text] [Related]
9. Automated SARS-COV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing.
Al-Saud H; Al-Romaih K; Bakheet R; Mahmoud L; Al-Harbi N; Alshareef I; Judia SB; Aharbi L; Alzayed A; Jabaan A; Alhadrami H; Albarrag A; Azhar EI; Al-Mozaini MA
Ann Saudi Med; 2020; 40(5):373-381. PubMed ID: 32954791
[TBL] [Abstract][Full Text] [Related]
10. An Infectious cDNA Clone of SARS-CoV-2.
Xie X; Muruato A; Lokugamage KG; Narayanan K; Zhang X; Zou J; Liu J; Schindewolf C; Bopp NE; Aguilar PV; Plante KS; Weaver SC; Makino S; LeDuc JW; Menachery VD; Shi PY
Cell Host Microbe; 2020 May; 27(5):841-848.e3. PubMed ID: 32289263
[TBL] [Abstract][Full Text] [Related]
11. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
12. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.
Herrmann A; Jungnickl D; Cordsmeier A; Peter AS; Überla K; Ensser A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638527
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
Pastorino B; Touret F; Gilles M; Luciani L; de Lamballerie X; Charrel RN
Viruses; 2020 Jun; 12(6):. PubMed ID: 32521706
[TBL] [Abstract][Full Text] [Related]
14. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.
Jureka AS; Silvas JA; Basler CF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32517266
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing.
Alessandrini F; Caucci S; Onofri V; Melchionda F; Tagliabracci A; Bagnarelli P; Di Sante L; Turchi C; Menzo S
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806776
[TBL] [Abstract][Full Text] [Related]
17. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.
Mendoza EJ; Manguiat K; Wood H; Drebot M
Curr Protoc Microbiol; 2020 Jun; 57(1):ecpmc105. PubMed ID: 32475066
[TBL] [Abstract][Full Text] [Related]
18. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.
Nagashima M; Kumagai R; Yoshida I; Kawakami M; Nagano M; Asakura H; Kaku E; Kitamura Y; Hasegawa M; Hayashi Y; Chiba T; Sadamasu K; Yoshimura K
Jpn J Infect Dis; 2020 Jul; 73(4):320-322. PubMed ID: 32350227
[No Abstract] [Full Text] [Related]
20. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
